Moxetumomab Pasudotox vs Sitagliptin
Moxetumomab Pasudotox vs Sitagliptin: Overview
This comparison examines the pharmacological differences between Moxetumomab Pasudotox and Sitagliptin.
Mechanism of Action
Sitagliptin: DPP-4 inhibitor increasing incretin levels.
Pharmacokinetics
Half-life: Sitagliptin — 12.4 hours.
Chemical Properties
Molecular Formula: Sitagliptin — C16H15F6N5O.
Molecular Weight: Sitagliptin — 407.3140 g/mol.
Type: Moxetumomab Pasudotox — Antibody drug conjugate; Sitagliptin — Small molecule.